Academic nephrologist · Institut Curie · France (FR) · Nephrology
Data minimisation
Cadence target for Tier 3: 1 per year (assumption)
1 of 1 expected engagements
No insights captured from engagements with this stakeholder.
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 10 Apr 2026 | Advisory board | In person | Dr. Anna Becker | Nephrada | Treatment burden and fatigueeGFR slope interpretation+1 | 0 | — | Reviewed | ENG-0164 |
| 16 Mar 2026 | Scientific exchange | In person | Dr. Anna Becker | Nephrada | eGFR slope interpretationPatient-reported outcomes | 0 | — | Reviewed | ENG-0161 |
| 14 Jan 2026 | Scientific exchange | Phone | Dr. Anna Becker | Nephrada | Patient-reported outcomesProteinuria as surrogate endpoint+1 | 0 | — | Reviewed | ENG-0144 |
10 Apr 2026
Treatment burden and fatigue, eGFR slope interpretation, APRIL pathway mechanism
16 Mar 2026
eGFR slope interpretation, Patient-reported outcomes
14 Jan 2026
Patient-reported outcomes, Proteinuria as surrogate endpoint, APRIL pathway mechanism
Institut Curie
Pathologist
Academic nephrologist
Academic nephrologist